Redman Heather B — SEC insider filings
SEC reporting owner CIK 1887532. 22 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2021-11-01 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PPL Corp (PPL) | Director | 21 | — | — | 21 |
| Brooklyn ImmunoTherapeutics, Inc. (BTX) | Director | 1 | — | — | 1 |
Insider filings — Redman Heather B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,335.47 (derivative) @ $32.76 | EDGAR |
| 2026-07-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,228.24 (derivative) @ $35.62 | EDGAR |
| 2026-04-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,140.21 (derivative) @ $38.37 | EDGAR |
| 2026-01-06 | 4 | PPL Corp (PPL) | Grant/award (A): 1,246.08 (derivative) @ $35.11 | EDGAR |
| 2025-10-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,161.52 (derivative) @ $36.59 | EDGAR |
| 2025-07-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,250.37 (derivative) @ $33.99 | EDGAR |
| 2025-04-03 | 4 | PPL Corp (PPL) | Grant/award (A): 1,178.59 (derivative) @ $36.06 | EDGAR |
| 2025-01-03 | 4 | PPL Corp (PPL) | Grant/award (A): 1,320.70 (derivative) @ $32.18 | EDGAR |
| 2024-10-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,203.73 (derivative) @ $33.23 | EDGAR |
| 2024-07-03 | 4 | PPL Corp (PPL) | Grant/award (A): 1,461.99 (derivative) @ $27.36 | EDGAR |
| 2024-04-02 | 4 | PPL Corp (PPL) | Grant/award (A): 1,454.55 (derivative) @ $27.50 | EDGAR |
| 2024-01-03 | 4 | PPL Corp (PPL) | Grant/award (A): 1,454.02 (derivative) @ $27.51 | EDGAR |
| 2023-10-03 | 4 | PPL Corp (PPL) | Grant/award (A): 1,718.40 (derivative) @ $22.55 | EDGAR |
| 2023-07-05 | 4 | PPL Corp (PPL) | Grant/award (A): 1,452.94 (derivative) @ $26.67 | EDGAR |
| 2023-04-05 | 4 | PPL Corp (PPL) | Grant/award (A): 1,405.00 (derivative) @ $27.58 | EDGAR |
| 2023-01-04 | 4 | PPL Corp (PPL) | Grant/award (A): 1,327.06 (derivative) @ $29.20 | EDGAR |
| 2022-10-04 | 4 | PPL Corp (PPL) | Grant/award (A): 1,486.95 (derivative) @ $26.06 | EDGAR |
| 2022-07-05 | 4 | PPL Corp (PPL) | Grant/award (A): 1,395.89 (derivative) @ $27.76 | EDGAR |
| 2022-04-04 | 4 | PPL Corp (PPL) | Grant/award (A): 1,335.29 (derivative) @ $29.02 | EDGAR |
| 2022-01-19 | 4 | Brooklyn ImmunoTherapeutics, Inc. (BTX) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | PPL Corp (PPL) | Grant/award (A): 1,285.67 (derivative) @ $30.14 | EDGAR |
| 2021-11-01 | 4 | PPL Corp (PPL) | Grant/award (A): 1,185.66 (derivative) @ $28.19 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-10-27 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1887532 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs